Kyinno Biotechnology
Latest round
- Series B
Last raised
- Feb 2025
Total raised
- $58M
Investors
- 16
About Kyinno Biotechnology
Established in 2017 and based in Beijing, China, Kyinno Biotechnology is a biotechnology company that focuses on research and development of tumor immunity and next-generation kinase inhibition. The company has 1,500 square meters Company floor area and 50 employees. The company self-developed products include stable cell line products such as kinase cell line, immune molecules cell line, reporter cell line, gene editing cell line, luciferase cell line and customized product development, and benchmark antibody products such as Isotype, therapeutic antibody, hybridoma and customized antibody products. Besides, the company provides in vivo or in vitro study service and antibody discovery service such as humanization & affinity maturation service, immunogenicity evaluation service and developability assessment service for customers. The company generates revenue from providing cell line products (including engineered cell lines, cancer cell lines, and antibodies) and services (including in vivo service, in vitro service and antibody discovery service).
Who invested in Kyinno Biotechnology
16 investors across 4 rounds
See all investors in Kyinno Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kyinno Biotechnology
Who invested in Kyinno Biotechnology?
Kyinno Biotechnology has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kyinno Biotechnology raised?
Kyinno Biotechnology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Kyinno Biotechnology last raise money?
Kyinno Biotechnology's most recent round on record is a Series B, in Feb 2025.
What does Kyinno Biotechnology do?
Established in 2017 and based in Beijing, China, Kyinno Biotechnology is a biotechnology company that focuses on research and development of tumor immunity and next-generation kinase inhibition.
Where is Kyinno Biotechnology headquartered?
Kyinno Biotechnology is headquartered in Beijing, China.
Which VCs invest in companies like Kyinno Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Kyinno Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kyinno Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.